Best-selling in Non-Fiction Books
Save on Non-Fiction Books
- AU $50.71Trending at AU $61.55
- AU $32.59Trending at AU $36.88
- AU $32.77Trending at AU $40.84
- AU $30.36Trending at AU $40.12
- AU $30.37Trending at AU $31.39
- AU $15.79Trending at AU $25.15
- AU $14.47Trending at AU $16.66
About this product
- DescriptionThe epigenetic regulation plays an important role in rmal development and maintenance of tissue specific genes expression in humans and the disturbance of these patterns lead to changes involved in tumor formation. More recently, epigenetic changes have been observed in early stages of tumor development and together with the genetic alterations have been defined as abrmalities, necessary for cancer initiation and progression. In, Cancer Epigenetics: Methods and Protocols, expert researchers reviewed these epigenetics changes in different tumor types and described several techlogies that are currently available to detect epigenetic changes. These techlogies have lead to a better understanding of the processes in rmal and cancerous cells. Written in the highly successful Methods in Molecular Biology(TM) series format, the chapters include the kind of detailed description and implementation advice that is crucial for getting optimal results in the laboratory. Thorough and intuitive, Cancer Epigenetics: Methods and Protocols aids scientists in continuing to study epigenetic alterations used in clinical practice as biomarkers of early cancerous lesions or markers of progression and progsis.
- PublisherHumana Press Inc.
- Date of Publication24/02/2012
- SubjectClinical Medicine: Professional
- Series TitleMethods in Molecular Biology
- Series Part/Volume Number863
- Place of PublicationTotowa, NJ
- Country of PublicationUnited States
- ImprintHumana Press Inc.
- Content Note10 black & white illustrations, 32 colour illustrations, 19 black & white tables, biography
- Weight1138 g
- Width178 mm
- Height254 mm
- Spine33 mm
- Edited byMukesh Verma,Ramona G. Dumitrescu
This item doesn't belong on this page.
Thanks, we'll look into this.